4.3 Article

Exendin-4, a Glucagon-Like Peptide-1 Receptor Agonist, Reduces Alzheimer Disease-Associated Tau Hyperphosphorylation in the Hippocampus of Rats With Type 2 Diabetes

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Cell Biology

Tau protein kinases: Involvement in Alzheimer's disease

Ludovic Martin et al.

AGEING RESEARCH REVIEWS (2013)

Review Geriatrics & Gerontology

The development of effective biomarkers for Alzheimer's disease: a review

Mark S. Henry et al.

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2013)

Article Clinical Neurology

Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimers Disease

Suzanne M. de la Monte

Current Alzheimer Research (2012)

Article Pharmacology & Pharmacy

Clarifying the Role of Incretin-Based Therapies in the Treatment of Type 2 Diabetes Mellitus

R. Keith Campbell

CLINICAL THERAPEUTICS (2011)

Article Pharmacology & Pharmacy

Current and Emerging Drug Treatment Options for Alzheimerʼs Disease

Nathan Herrmann et al.

Article Pharmacology & Pharmacy

Mechanism-based population modelling for assessment of L-cell function based on total GLP-1 response following an oral glucose tolerance test

Jonas B. Moller et al.

JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2011)

Article Geriatrics & Gerontology

Targeting Tau Protein in Alzheimer's Disease

Cheng-Xin Gong et al.

DRUGS & AGING (2010)

Article Biochemistry & Molecular Biology

Phosphatidylinositol 3-Kinase (PI3K) Signaling via Glycogen Synthase Kinase-3 (Gsk-3) Regulates DNA Methylation of Imprinted Loci

Anthony P. Popkie et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

Editorial Material Multidisciplinary Sciences

Linking type 2 diabetes and Alzheimer's disease

Weiping Han et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Endocrinology & Metabolism

Evidence that Intestinal Glucagon-Like Peptide-1 Plays a Physiological Role in Satiety

Diana L. Williams et al.

ENDOCRINOLOGY (2009)

Article Biochemistry & Molecular Biology

Brain glucose transporters, O-GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer's disease

Ying Liu et al.

JOURNAL OF NEUROCHEMISTRY (2009)

Article Biochemistry & Molecular Biology

Glucagon-like peptide-1 receptor is involved in learning and neuroprotection

MJ During et al.

NATURE MEDICINE (2003)

Article Pharmacology & Pharmacy

Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4

T Perry et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)